Search:
 

The Pharmaceutical Market: India

 

NEW YORK, June 26, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:



The Pharmaceutical Market: India

http://www.reportlinker.com/p0203061/The-Pharmaceutical-Market-India.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pharmaceutical



Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting the pharmaceutical market in context. The reports provide:




Five-year projections for economic, demographic, health expenditure, health workforce and pharmaceutical market indicators.


Specialised intelligence on OTCs, generics, biologics and biosimilars.


Exclusive economic and demographic data from the Economist Intelligence Unit (EIU) for each market in the series.


A separate statistical health file, comprising health expenditure, health infrastructure, health services and health personnel.


The reports are updated quarterly, providing you with the latest information for a full year. In addition, the service will keep you up to date with market and industry news on a regular basis.





TABLE OF CONTENTS

EXECUTIVE SUMMARY 1


Snapshot: Strategic Espicom Analysis 2


Snapshot: Key Data Projections3


MACROENVIRONMENT 4


POLITICAL 4


ECONOMIC5


Projections 5


LEGAL 6


Background to Pharmaceutical Patents 6


Mashelkar Committee Report, December 2006 6


The Patents (Amendments) Bill, 2005 7


Compulsory Licensing 7


Pre- & Post-Grant Opposition 8


Mailbox Applications 8


Other Issues 9


The Patents (Amendment) Rules, 2006 9


Previous Patents Act Amendments and Exclusive Marketing Rights 10


Challenges and Patent Decisions in the Indian High Courts 10


Novartis Once Again Challenges the Indian Patents Act 10


Bayer's Nexavar Patent Challenged by Compulsory Licence Application 11


US Special 301 Report - India Remains on Priority Watch List 12


DEMOGRAPHIC 12


Population 12


Demographic Indicators 14


Births 14


Deaths 14


Infant Mortality 14


Life Expectancy at Birth 14


EPIDEMIOLOGY 16


DISEASE BURDEN 16


Leading Causes of Mortality 16


DISEASE PREVALENCE17


Communicable Diseases 17


HIV/AIDS 19


Leprosy20


Tuberculosis20


Vector Borne Diseases 21


Non-Communicable Diseases 21


Blindness 21


Cancer 21


Diabetes, Cardiovascular Disease and Stroke22


National Rural Health Mission22


HEALTHCARE - ACCOMPANYING HEALTH STATISTICS 24


ORGANISATION 24


Public Sector 24


Department of Health and Family Welfare 24


Department of AYUSH 25


Private Sector 25


Health Insurance 26


EXPENDITURE 27


Projections 27


Latest Figures 28


INFRASTRUCTURE 29


Hospital Infrastructure29


Private Hospitals and Clinics30


Apollo Hospitals Group 30


Fortis Healthcare 30


Max Healthcare 30


Wockhardt Hospitals30


Other Commercial Providers 31


Ambulatory Infrastructure31


Primary Care 31


First Aid and Disaster Relief 32


WORKFORCE 32


Projections 32


Latest Figures 33


REGULATORY AFFAIRS 35


NATIONAL AUTHORITY 35


REGULATORY DEVELOPMENTS 36


New Drug Advisory Committees36


MARKETING REGISTRATION 37


DGCI Set to Co-ordinate Drug Approvals 38


PROMOTION 38


PRICING 39


Drugs (Prices Control) Amendment Order and Second Amendment Order, 2006 39


Draft National Pharmaceuticals Pricing Policy, 2011 40


DISTRIBUTION CHANNELS 42


Medical Stores Organisation 42


Pharmacy Chains 42


Apollo Pharmacy 42


Guardian Lifecare 42


Religare Wellness 42


98 4 42


MARKET ANALYSIS 43


SIZE 43


Projections 43


Historical Figures 46


Current Structure 47


PRODUCT DEVELOPMENT 48


Traditional Indian Medicines 49


MANUFACTURING 51


TRADE52


Exports 52


Imports 54


Balance of Trade 58


COMPETITION 59


Foreign Direct Investment in the Pharmaceutical Industry under Review 59


TRADE ASSOCIATIONS 60


TRADE FAIRS 60


Bangalore Bio 201260


India Chem 2012 60


Pharma World EXPO 60


COMPANY INTELLIGENCE61


Foreign Private Producers 61


Abbott 61


Actavis 61


Bayer Healthcare 61


Daiichi Sankyo 62


GlaxoSmithKline 62


Mylan62


Pfizer India63


Reckitt Benkiser63


Sanofi63


Local Private Producers 64


Alembic Ltd 64


Aurobindo Pharma66


Cipla Ltd 68


Claris Lifesciences71


Dr Reddy's Laboratories Ltd 72


Glenmark Pharmaceuticals 75


Jubilant Life Sciences78


Lupin Limited 79


Natco Pharma 82


Orchid Chemicals & Pharmaceuticals Ltd 84


Piramal Healthcare 87


Ranbaxy Laboratories 89


Strides Arcolab 92


Sun Pharma 94


Torrent Pharmaceuticals97


Wockhardt Ltd 99


Zydus Cadila 102


COMPETITIVE STRATEGIES 106


Recent Acquisitions & Divestitures 106


Agreements 106


BIOLOGICS & BIOSIMILARS 108


COMPETITION 108


Company Intelligence108


Avesthagen 108


BCG Vaccine Laboratory, Chennai109


Biocon109


Cipla 111


Claris Lifesciences 111


Dr Reddy's111


Glenmark Pharmaceuticals 112


Lupin 112


Panacea Biotec 113


Ranbaxy/Daiichi Sankyo 113


Wockhardt 114


Zydus Cadila 114


COMPETITIVE STRATEGIES 115


CONCLUSIONS: OPPORTUNITIES & CHALLENGES 116


Strategic Espicom Analysis 116


MACROENVIRONMENT 116


EPIDEMIOLOGY 116


HEALTHCARE 117


REGULATORY AFFAIRS 117


PRICING & REIMBURSEMENT 117


DISTRIBUTION CHANNELS 118


MARKET 118


COMPETITION 118


OTC PHARMACEUTICALS 118


GENERICS 118


BIOLOGICS & BIOSIMILARS 119


Radar & SWOT Analysis 121


DIRECTORY 122


GOVERNMENT ORGANISATIONS 122


PHARMACEUTICAL COMPANIES 123


TRADE ASSOCIATIONS 123



List of Tables

Espicom Analysis of the Pharmaceutical Market, 2012 2


Key Data Projections, 2012-2017 3


Political Landscape, 2012 4


Regional Ranking of Projected Economies, 2017 5


Projected Economy, 2012-2017 5


Regional Ranking of Projected Demographics, 2017 13


Projected Demographics, 2012-2017 13


Summary of Demographic Data 15


Demographic Indicators, 2000-2010 15


Deaths from Communicable Diseases, 2004-2009 16


Reported Incidence of Communicable Diseases, 2005-2009 17


Reported Incidence of Vaccine Preventable Diseases, 2008-2010 18


Regional Ranking of Projected Health Expenditure, 2017 27


Projected Health Expenditure, 2012-2017 27


Health Expenditure, 2011 28


Regional Ranking of Projected Physicians, 2017 32


Projected Physicians, 2012-2017 33


Doctors Registered with State Medical Councils, 2007-2010 33


Regional Ranking of Projected Pharmaceutical Markets, 2017 43


Asia Pacific Market Share, 2017 44


Projected Pharmaceutical Market at Retail Prices, 2012-2017 45


Historical Pharmaceutical Market at Retail Prices, 1995-2010 (US$ Million)46


Pharmaceutical Exports by Category, 1995-2010 (US$000s) 52


Pharmaceutical Exports by Country/Region, 2010 (US$000s) 53


Pharmaceutical Imports by Category, 1995-2010 (US$000s) 54


Imports of Raw Materials by Country/Region, 2010 (US$000s) 55


Imports of Antisera & Vaccines by Country/Region, 2010 (US$000s) 56


Imports of Medicaments by Country/Region, 2010 (US$000s) 57


Balance of Pharmaceutical Trade, 1995-2010 (US$000s) 58


Foreign Acquisitions of Indian Pharmaceutical Companies, 2007-2011 59


Alembic: Financial Results, 2007-2011 64


Alembic: Manufacturing Facilities 65


Aurobindo Pharma: Financial Results, 2007-2011 66


Aurobindo Pharma: Manufacturing Facilities 67


Cipla: Financial Results, 2007-2011 68


Cipla: Manufacturing Facilities 70


Dr Reddy's: Financial Summary, 2007-2011 73 Dr Reddy's: Manufacturing Facilities 74


Glenmark: Financial Results, 2007-2011 75


Glenmark: Manufacturing Facilities 77


Jubilant Life Sciences: Financial Results, 2010-2011 78


Lupin: Financial Results, 2007-2011 80


Lupin: Manufacturing Facilities 81


Natco Pharma Financial Results, 2007-2011 82


Orchid: Financial Results, 2007-2011 85


Orchid's Top-10 Brands 85


Orchid: Manufacturing Facilities 86


Piramal Healthcare: Financial Results, 2007-2011 87


Piramal Healthcare: Manufacturing Facilities 88


Ranbaxy: Financial Results, 2006-2010 89


Ranbaxy: Manufacturing Facilities 91


Strides: Financial Results, 2006-2010 92


Sun Pharma: Financial Results, 2007-2011 94 Sun Pharma: Manufacturing Facilities 96


Torrent Pharma: Financial Results, 2007-2017 97


Wockhardt: Financial Results, 2006-2011 99 Wockhardt Manufacturing Facilities 101


Zydus Cadila: Financial Results, 2007-2011 103


Zydus Cadila: Manufacturing Facilities 105


Biocon: Financial Results, 2007-2011 110


Panacea Biotec: Financial Results, 2007-2011 113


Espicom Analysis of the Pharmaceutical Market, 2012 120


SWOT Analysis of the Pharmaceutical Market, 2012 121



List of Charts

Population by Age Group (%)12


Regional Comparison of Top 5 Projected Pharmaceutical Markets at Retail Prices, 2017 44


Regional Comparison of Projected Pharmaceutical Market Share, 2017 45


Historical Pharmaceutical Market at Retail Prices, 1995-2010 47


Pharmaceutical Exports, 1995-2010 (US$ Millions) 52


Pharmaceutical Imports, 1995-2010 (US$ Millions) 54


Pharmaceutical Imports by Country/Region, 2010 (%) 55


Balance of Pharmaceutical Trade, 1995-2010 (US$ Millions) 58


Radar Graph of the Pharmaceutical Market, 2012 121








To order this report:
Pharmaceutical Industry:
The Pharmaceutical Market: India


More  

Market Research Report



Check our  

Industry Analysis and Insights


CONTACT
Reportlinker
Email: nicolasbombourg@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker

Back to top

RELATED LINKS
http://www.reportlinker.com